14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
PMAX vs VRXA: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Powell Max Limited Class A (PMAX) is the stronger overall head-to-head candidate over VRXA (VRXA) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). PMAX carries a Unified Composite Score of 37.0/100 (SELL) at $0.56 (N/M Forward P/E, -24.9% operating margin), whereas VRXA carries 41.6/100 (SELL) at $1.04 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While VRXA currently prints a higher short-term Unified Composite Score (41.6/100 SELL vs. PMAX 37.0/100 SELL), PMAX captures the overall institutional head-to-head verdict (6–2 matrix metrics and 4–0 across the 6 pillars) due to superior fundamental profitability (-24.9% vs. N/A operating margin) and revenue trajectory (+72.7% vs. N/A YoY).
Defensive Composite Rating Caution: Although PMAX compares more favorably head-to-head, both PMAX (37.0/100 SELL) and VRXA (41.6/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Technical & Structure Timing Caution: PMAX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.4); meanwhile VRXA trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 46.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PMAX vs VRXA. Trailing 12-month operating profitability (PMAX -24.9% vs VRXA N/A) and valuation multiples (PMAX N/M vs VRXA N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ PMAX vs VRXA Key Questions & Quantitative Answers
As of Nov 20, 2026, Powell Max Limited Class A (PMAX) is the stronger overall head-to-head candidate over VRXA (VRXA) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 4–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). PMAX carries a Unified Composite Score of 37.0/100 (SELL) at $0.56 (N/M Forward P/E, -24.9% operating margin), whereas VRXA carries 41.6/100 (SELL) at $1.04 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While VRXA currently prints a higher short-term Unified Composite Score (41.6/100 SELL vs. PMAX 37.0/100 SELL), PMAX captures the overall institutional head-to-head verdict (6–2 matrix metrics and 4–0 across the 6 pillars) due to superior fundamental profitability (-24.9% vs. N/A operating margin) and revenue trajectory (+72.7% vs. N/A YoY). Defensive Composite Rating Caution: Although PMAX compares more favorably head-to-head, both PMAX (37.0/100 SELL) and VRXA (41.6/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: PMAX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 41.4); meanwhile VRXA trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 46.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
PMAX leads the Growth & Scale pillar: PMAX posts +72.7% YoY revenue growth and -78.7% YoY earnings growth on $48M TTM revenue (49.5% gross margin, -24.9% operating margin), compared with VRXA at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, PMAX generates $48M in USD-normalized revenue versus N/A for VRXA. In operating R&D and SG&A reinvestment, PMAX deploys 74.4% of Rev ($35M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for VRXA.
PMAX and VRXA trade at balanced relative valuation multiples. PMAX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (-17.3% EBITDA margin), whereas VRXA trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PMAX (-101.8% ROE) versus VRXA (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, PMAX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (10.65β · 239% Vol realized risk). By comparison, VRXA carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.16β · 104% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.